Skip to main content
Infectious Disease Modelling logoLink to Infectious Disease Modelling
. 2021 Jul 24;6:955–974. doi: 10.1016/j.idm.2021.06.008

Large-scale frequent testing and tracing to supplement control of Covid-19 and vaccination rollout constrained by supply

Lia Humphrey a, Edward W Thommes a,b, Roie Fields a, Laurent Coudeville b, Naseem Hakim c, Ayman Chit d, Jianhong Wu e, Monica G Cojocaru a,
PMCID: PMC8302824  PMID: 34337194

Abstract

Non-pharmaceutical interventions (NPI) were implemented all around the world in the fight against COVID-19: Social distancing, shelter-in-place, mask wearing, etc. to mitigate transmission, together with testing and contact-tracing to identify, isolate and treat the infected. The majority of countries have relied on the former measures, followed by a ramping up of their testing and tracing capabilities. We present here the cases of South Korea, Italy, Canada and the United States, as a look back to lessons that can be drawn for controlling the pandemic, specifically through the means of testing and tracing. By fitting a disease transmission model to daily case report data in each of the four countries, we first show that their combination of social-distancing and testing/tracing have had a significant impact on the evolution of their first wave of pandemic curves. We then consider the hypothetical scenario where the only NPI measures implemented past the first pandemic wave consisted of isolating individuals due to repeated, country-scale testing and contact tracing, as a mean of lifting social distancing measures without a resurgence of COVID-19. We give estimates on the average isolation rates needed to occur in each country. We find that testing and tracing each individual of a country, on average, every 4.5 days (South Korea), 5.7 days (Canada), 6 days (Italy) and 3.5 days (US), would have been sufficient to mitigate their second pandemic waves. We also considered the situation in Canada to see how a frequent large-scale asymptomatic testing and contact tracing could have been used in combination with vaccination rollout to reduce the infection in the population. This could offer an alternative approach towards preventing and controlling an outbreak when vaccine supply is limited, while testing capacity has been increasingly enhanced.

Keywords: Pandemic modelling, Pandemic evolution scenarios, Testing frequency policy modelling

1. Introduction

In late 2019, a novel betacoronavirus called SARS-CoV-2 emerged from a live animal marketplace in Wuhan, Hubei Province, China, and has since inflicted a worldwide pandemic of a disease now referred to as COVID-19. The disease is highly contagious, with an estimated R0 between 2.2 and 4.6 (Anastassopoulou, Russo, Tsakris, & Siettos, 2020; Guan et al., 2020) although it is important to consider that R0 is not strictly biologically determined but rather heavily influenced by host behavioural and environmental factors (1112Neher, Dyrdak, Druelle, Emma, & Albert, ). The incubation period has been found to be 5.1–5.2 days, while 97.5% of patients display symptoms within 11.5 days (Guan et al., 2020; Lauer et al., 2020). The disease spreads primarily through the respiratory tract, through droplets and aerosols. Outbreaks continued throughout the world in 2020 and in 2021, with new cases reported daily. Most countries have passed a first wave in March–May of 2020 and a second wave in November 2020–January 2021, while many are in the midst of a new wave, under the presence of mutated, more infectious variants of concern (University of Manitoba, 2021). Countries have taken various degrees of social distancing measures: lockdown, shelter-in-place, banning gatherings and sport events, closing schools, mask-wearing etc. (e.g. (Ashleigh et al., 2020a; Ashleigh et al., 2020b; Centor & Fisman, 2020; Cereda et al., 2003, p. 2020; Ferguson et al., 2020; Tang et al., 2020)) in an effort to suppress disease transmission, or at least prevent it from reaching levels that would overwhelm a country's critical care capacity. While proven effective to slow the spread, these measures have had a large effect on daily lives and economies throughout the world. Countries which managed to stave off their first waves have been implementing (in various degrees) relaxation measures during June–September of 2020, in an effort to restore, as much and as safe as possible, their socio-economic landscapes. The cycle of measures repeated itself during the second and third waves of the pandemic.

In this paper we are interested in examining the degree of success in staving off pandemic waves in four developed countries (Italy, Canada, South Korea and United States) when social distancing measures are paired with country-scale repeated testing and tracing strategies, which would have allowed more phasing out social distancing measures while preventing a resurgence of outbreaks (Kissler, Tedijanto, Goldstein, Grad, & Lipsitch, 2020; Laydon et al., 2020; Tindale et al., 2020). To start, fitting a disease transmission model to daily case reports in each country above allows the assessment of effectiveness of their COVID-19 countermeasures at two intermediate points in their pandemic history: passed their first wave - July 2020 and during their second wave - November 2020.

The analysis begins with Italy, Canada and the United States, three countries which have relied principally on social distancing and mask-wearing via universal shelter-in-place measures, while testing and contact tracing was implemented at an increased pace only after the first pandemic wave was more-or-less established in their populations. It continues on with South Korea, a country which has had a tighter control on COVID-19 through a combination of early aggressive testing and contact tracing, paired with social-distancing measures, but avoiding economic and social lockdown.

A policy scenario involving country-wide repeated asymptomatic testing and tracing could have avoided a second pandemic wave in Canada and Italy which can be seen by comparison with the past pandemic evolution data. On the other hand, relaxation of social-distancing combined with population's fatigue and lower levels of compliance through the summer and fall have led directly to a second wave, and again to various degrees of lockdown measures. This could have been avoided through scaling up frequency of testing and tracing in the population at large, rather than lockdown measures, resulting in lower pandemic waves. Specifically, an average frequency of testing every individual every 4.5 days (and tracing contacts of discovered infected individuals) in Canada and Italy would have suffice in keeping incidence rates under control. A similar analysis for the United States and South Korea is presented together with frequencies of testing and tracing for their populations.

Last but not least, the work is brought into the present in the specific case of Canada, by implementing the proposed repeated large-scale asymptomatic testing and tracing policy with the current Canadian vaccination campaign (over January–April 2021), in the presence of variants of concern and their much more infectious nature, in line with current expert opinions (2021Cojocaru, Najafabadi, Wu, & Asgary, ; Liu, Arora, & Krajden, 2021; Polack et al., 2020; SchwartzAllison and Isaac, 2021). It is seen that, due to the vaccination impact, an average frequency of 30 days for every individual in Canada would have reduced the current incidence number by 12%, while a testing frequency of 20 days would have avoided the current third wave. This, once again, shows the power of large scale asymptomatic testing, as a middle ground between sever lockdown/social-distancing measures and controlled incidence while vaccination ramps up.

The structure of the paper is as follows: Section 2 introduces our model's main ideas, notation, and assumptions. Section 3 presents the fitted infection curves for Italy, Canada, the U.S. and South Koreaand evaluates scenarios for countries to phase out social distancing while preventing a resurgence of COVID-19 outbreaks. Section 3 also presents the frequencies with which a tested (infected) individual and an exposed (traced) individual needed to be detected and isolated in order for each country to maintain an effective reproduction number of 1 (that is to say, each country maintains a “slow burn” of their pandemic), while assuming a major relaxation of social-distancing rules. Section 4 shows that repeated asymptomatic testing and tracing, together with vaccination campaigns could have avoided lockdown and would have reduced daily incidence considerably in Canada, over January to May 2021, for a frequency of 10, 14, 20, respectively 30 days. The paper closes with a thorough discussion of challenges and opportunities presented by the proposed policy in Section 5. Additional mathematical background is included in Appendix.

2. Materials and methods

2.1. The SEIRL model

The transmission of an infectious disease in a homogeneously mixed population is often described by a Susceptible-Infectious-Recovered (SIR) model (Ogilvy Kermack & McKendrick, 1927; van den Driessche, 2017), or its variants, most notably a Susceptible-Exposed-Infectious-Recovered (SEIR); see (Ma, 2020) for a recent review. A SEIR model normalized to a population of size N is described by:

dsdt=βsi,dedt=βsiσe,didt=σeγi,drdt=γi, (1)

with s=SN,e=EN,i=IN,r=RN, s + e + i + r = 1 and where β is the rate of effective contacts, 1/σ = Tlat is the mean latent period (which may differ from the incubation period), and 1/γ = Tinf is the mean duration of infectiousness, with both times having exponential distributions. We also have the auxiliary equation for the cumulative number of cases,

dcdt=σe.

The daily incidence of cases on day t is then

inct=ctct1,

The spread of an infectious disease can be halted if its effective reproduction number Reff = R0s can be decreased below 1. The effective reproduction number of the SEIR compartmental disease transmission models is

Reff=βγs. (2)

When s ≈ 1 and we are near the disease-free equilibrium (1, 0, 0, 0), the early growth of both i and inc is exponential (see e.g. (Ma, 2020)):

i(t)=i0eρt,inc(t)=inc0eρt, (3)

In the SEIR model we can estimate the growth factor near the DFE as in (Ma, 2020):

ρSEIR=(σ+γ)+(σγ)2+4σβ2, (4)

and by solving for β from Equation (4) we get:

R0SEIR=(ρSEIR+σ)(ρSEIR+γ)σγ. (5)

For COVID-19, as for other pandemics (e.g. SARS, MERS, the 1918 Spanish flu), we can assume the entire population to be initially susceptible. Therefore, in the early stages of an outbreak, Reff ≈ R0. We will also assume that infection with COVID-19 confers subsequent immunity, which does not wane significantly over the time horizon considered here. Thus, whether they die or recover, an infected person is considered removed from the pool of susceptibles. In the absence of a vaccine or other control measures, s(t) = 1 − c(t), where c(t) is the cumulative number of people infected at time t.

From Equation (2), assuming β to be given, we see that Reff can be decreased in two ways: by decreasing s at a rate higher than that due to infection alone (for instance by quarantine and lockdown; or by increasing γ. The former can be considered as an abstraction of social distancing measures, since these effectively take a part of the population “out of circulation” as far as disease transmission is concerned. The latter can be achieved by identifying and isolating infected individuals early, thus cutting short Tinf.

To explicitly depict the role of control measures, we adapt the SEIR model to a pandemic setting by adding an isoLated (L) compartment. As before, we include the auxiliary equation for C, the cumulative number of infected. The resulting SEIRL model, is described by:

dsdt=βsi,dedt=βsiσeκ1e,didt=σe(γ+κ)i,drdt=γi,dldt=κi+κ1e,dcdt=σe,

where, as in the standard SEIR model, β is the mean rate of effective contacts, 1/σ = Tlat is the mean latent period, and 1/γ = Tinf is the mean infectious period. Finally, 1/κ1 = Tisol,lat and 1/κ = Tisol,inf are the mean times for the latent and infectious, respectively, to be isolated as a consequence of asymptomatic testing and contact tracing, respectively.

Its effective reproduction number is then given by (see Appendix as adapted from (Ma, 2020)):

Reff,SEIRL=sβσ(σ+κ1)(γ+κ). (6)

It can be shown (see Appendix) that the exponential growth rate (Equation (3)) of infected near the disease-free equilibrium is

ρSEIRL=(σ+κ1+γ+κ)2+((σ+κ1)(γ+κ))2+4σβs2, (7)

and the rate of effective contacts is 1

βSEIRL=(σ+κ1+ρSEIRL)(γ+κ+ρSEIRL)σ.

We can also express the effective reproduction number in terms of ρSEIRL:

R0SEIRL=(σ+κ1+ρSEIRL)(γ+κ+ρSEIRL)(γ+κ)σ.

2.2. Estimating R0 from early exponential growth

While growth is still exponential, it follows from Equation (3) that

log(inc(t))ρt, (9)

i.e. a log-linear plot of incidence versus time will have slope ρ. Indeed, early exponential growth can be seen to be a near-universal feature in COVID-19 daily case count data from around the world. Fig. 1, Fig. 2 plot log(inc) versus time for South Korea, Italy, Canada and the U.S., using time series data of daily new cases compiled by the Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE) (Dong, Du, & Gardner, 2020), retrieved from (John's hopkins covid-19 d, 2021).

Fig. 1.

Fig. 1

Log-linear plots of daily COVID-19 incidence versus time for South Korea and Italy. The initial linear phase corresponds to exponential growth, which subsequently turns over into sub-exponential growth. The factor ρ and the corresponding doubling time are estimated via a regression fit to the initial phase. R0 is calculated using Eq. (5) with σ = γ = (2.5 d)−1.

Fig. 2.

Fig. 2

Log-linear plots of daily COVID-19 incidence versus time for Caada and the United States. The initial linear phase corresponds to exponential growth, which subsequently turns over into sub-exponential growth. The factor ρ and the corresponding doubling time are estimated via a regression fit to the initial phase. R0 is calculated using Eq. (5) with σ = γ = (2.5 d)−1.

In all four countries the initial linear phase is clearly apparent, followed by a transition to sub-exponential growth. This transition is sharpest for South Korea, where growth switches abruptly to decay around 1 March. Regression fit results for ρ and the corresponding doubling time,

Tdbl=ln(2)ρ, (10)

together with dates for the onset of major national-level protective measures, are given in Fig. 1, Fig. 2 and Table 1. In all four cases, the transition to sub-exponential growth occurred at or after the time that widespread protective measures were first invoked.

Table 1.

Initial exponential growth rates and R0 values for South Korea, Italy, Canada, and the U.S.

Country ρ initial growth R0
S. Korea 0.22(0.15,0.29) 2.38(1.88,2.94)
Italy 0.18(0.16,0.2) 2.1(1.98,2.22)
Canada 0.18(0.16,0.2) 2.11(1.97,2.26)
U.S.
0.3(0.27,0.33)
3.07(2.81,3.35)

counter-measures
sub-exponential onset
S. Korea Feb 21 (McNeil, 2020) March 1
Italy March 12 (D'Emilio, 2020) March 22
Canada March 20 (CBC News, 2020) April 3
U.S. March 13 (Alvarez, 2020) April 6

Estimates of initial exponential growth rate ρ are obtained from regression fits to the early outbreak phases (Fig. 1, Fig. 2). Corresponding values of R0 assume Tlat = Tinf = 2.5 days. Estimates of the fraction of cases reported are taken from (Russell et al., 2020), see also (Russellet al., 2020).

Inferring R0 from ρ requires choosing values for the mean latent (1σ) and infectious (1γ) periods. The sum of these is the mean serial interval:

Tser=Tlat+Tinf=σ1+γ1. (11)

Estimates of the serial interval of COVID-19 range from 3.95 to 6.6 days (Bi et al., 2020; Cereda et al., 2003, p. 2020; Ganyani et al., 2020; Tindale et al., 2020). We adopt a value of Tser = 5 days. The latent period, 1σ of the disease is not well constrained, but it can be shown (Appendix A) that for a given value of Tser and ρ, the maximum value of R0 is obtained when Tlat = Tinf = Tser/2. We assume this “worst-case” scenario and let Tlat = Tinf = 2.5 days.

2.3. Quantifying the effectiveness of COVID-19 countermeasures until November 2020

We begin with the remark that all 4 countries have enacted social distancing via school closures, nationwide shutdowns, shelter-in-place orders, mask wearing, etc., all in various combinations. South Korea was the first to impose measures (February 2020), followed by Italy, where the measures were ordered and coordinated eventually country-wide. In Canada most provinces enacted similar measures over the course of 1–2 weeks around March 20, 2020, while the United States has had the more heterogeneous spread of similar measures, depending on specific states.

The measures in these three countries were similar, in that schools and universities were closed, non-essential businesses were closed, anybody who could transitioned to working from home, with the exception of front-line workers, travel was restricted, both national and international, etc. However, each country implemented these in a different way. Italy has gradually worked up to the eventual lockdown phase (see (McNeil, 2020) throughout February and Ma, 2020) lockdown has been lifted through Ma, 2020. Italy reimposed some regional lockdown in November 2020. Canada has imposed a lockdown between March 11 and March 15, 2020 ((CBC News, 2020) then lifted it over the course of early summer 2020. Canada reimposed some regional lockdown in November 2020.) The United States had a heterogeneous approach (with states affected early, such as New York, Washington, California imposing shelter-in-place policies in March) followed by others after an emergency declaration nation-wide on March 13, 2020. The heterogeneity in social-distancing measures has continued in US, where the pandemic went through a subsequent second and a third wave. Finally, US was heterogeneous with respect to mask-wearing throughout 2020, while Canada and Europe have adopted mask-wearing in public, in retail and business places, in schools, etc. Schools re-opened in US, Canada and Europe in Fall 2020.

South Korea has followed a different model from the other three countries. Instead of lockdown and shelter-in-place, they increased production and implementation of testing and tracing to a large scale (using electronic tracing of contacts and enforced isolation (McNeil, 2020)), while having the added benefit that mask-wearing is a well-adopted and established social norm. Schools have continued to function in South Korea under social-distancing guidelines.

For each country, we fit the SEIR model solutions for daily incidence {incmodel,1, …, incmodel,n} to daily case reports. The model output is multiplied by a factor kf, where k is an estimate of the fraction of symptomatic cases reported, obtained using delay-adjusted case fatality rates (Russellet al., 2020), and f is the fraction of cases which are symptomatic, estimated to be f = 0.5, from a recent CDC report .2

We interpret the transition from exponential to sub-exponential growth (see Fig. 1, Fig. 2) as the first signature of the effect of these restrictive measures in a given country, and use this as the starting point to infer the net effect that these measures have had up to the end of June 2020.

We compute logL, the normal negative log likelihood of the time series of observed daily incidences, {incobs,1, …, incobs,n}, given the model output, as a function of model parameters

x=i0,q1,q2,,qm

where i0 is the initial number of infected and the qi are reduction factors on the rate of disease transmission, varying over time, such that βi′ = qiβ (see Table 1). R0 for each country is fixed at the respective values obtained via regression above. Parameters are drawn using unweighted (uniform) Latin hypercube sampling. The best-fit solution is the one which minimizes L. We estimate the 95% confidence interval as comprising all solutions having logL(logL)min+1.92 (see e.g. (Cowan, 1998)

We present our best fits for Italy (in Fig. 14), Canada (in Fig. 3), the U.S. (in Fig. 16) and South Korea (in Fig. 15) below, including the following curves:

  • Linear and semi-log plots of daily incidence data of confirmed cases per country, together with maximum-likelihood model fit (“with measures, confirmed”).

  • Inferred true number of infected, taking into account under-reporting and asymptomatic cases (“with measures, all”). Shown for comparison are the number of confirmed cases (“no measures, confirmed”) and all cases (“no measures, all”) expected to have occurred in the absence of countermeasures.

  • Cumulative incidence and inferred reduction in effective contact rates (qiβ) due to social-distancing, mask wearing etc.

  • These fits assume κ = κ1 = 0, in other words, the reduction in the effective contact rates qi's are a measure of each country's combination of measures to date, including social-distancing, testing and tracing.

Fig. 3.

Fig. 3

Canada - daily incidence and log-daily incidence fits to November 2020: Linear and semi-log plots of daily incidence data of confirmed cases, together with maximum-likelihood model fit (“with measures, confirmed”) Also shown is the inferred true number of infected, taking into account under-reporting and asymptomatic cases (“with measures, all”). Shown for comparison are the number of confirmed cases (“no measures, confirmed”) and all cases (“no measures, all”) expected to have occurred in the absence of countermeasures.

To illustrate further that social-distancing and lockdown measures were not enough as a central focus to control the pandemic, we present here our model for all four countries through to November 2020, when the countries were in the second wave. We include here Canada and its pandemic profile below in Fig. 3, while Italy, South Korea and US are included in Figs. 14–16 in Appendix.

In Canada interventions managed the initial exponential rise in cases and brought the effective reproduction number below 1. Daily case numbers entered a second wave in the Fall of 2020. From Fig. 12, Canada maintained an average of 40%–50% reduction in the transmission rate β through social distancing measures (see Fig. 4).

Fig. 12.

Fig. 12

Modelled cummulative vaccinated numbers in Canada Janury-April 2021.

Fig. 4.

Fig. 4

Canada - daily incidence and log-daily incidence fits to November 2020: Cumulative incidence (top) and inferred reduction of effective contacts (β), together with the corresponding effective reproduction numbers (vertical numbers) (bottom).

3. Large-scale frequent testing and tracing as a way to relax social-distancing measures and control the spread beyond July 2020

3.1. Theoretical estimates after the first pandemic wave - the SEIRL model

As presented in Section 2, for a given set of values of β, σ and γ, Equation (6) gives us a closed form expression for Reff, SEIRL as a function of κ and κ1. This relationship is depicted as a surface plot in Fig. 5 for σ=γ=12.5 and σ=γ=15. In the former case, Reff, SEIRL is nearly twice as large as in the latter. It is interesting to note, though, that for both cases, the combinations of κ and κ1 that make Reff, SEIRL = 1 (i.e. the intersections of the respective surfaces with the R0 = 1 plane) are quite similar. This can be understood as follows: As σ and γ become small compared to κ1 and κ, respectively, it is the value of κ which becomes more important for determining the rate at which exposed/infected people are isolated.

Fig. 5.

Fig. 5

Effects of isolation rates due to testing and contact tracing on the initial value of R0SEIRL model. We computed σ=γ=12.5 (upper most surface), σ=γ=15 (middle surface) and the reference surface R0 = 1.

From Equation (6), we obtain the relationship between κ and κ1 that makes Reff, SEIRL = 1:

1=sβσ(σ+κ1)(γ+κ)κ=sβσσ+κ1γ. (12)

Extracting the current values of s from our simulations of the last section, we can now compute average isolation rates due to testing and tracing that would have ensured an effective reproduction number of 1, while assuming that the effective contact rates β would reverse to their values near the disease-free equilibrium, before any other social distancing measures were employed. We further assume that the isolation rate due to contact tracing (κ1) is the same as the isolation rate due to testing (κ). We present our results compactly in Table 2 below.

Table 2.

Model results for South Korea, Italy, Canada, and the U.S. for Reff = 1.

β s Reff κ = κ1 (1κ, 1κ1)
SK 0.961 0.999 1 0.22 (4.5, 4.5) days
Italy 0.841 0.937 1 0.161 (6.2,6.2) days
Can 0.841 0.982 1 0.175 (5.7,5.7) days
U.S. 1.225 0.96 1 0.288 (3.5, 3.5) days

In all cases, we chose γ=σ=12.5 for a Tser = 5 days and where s are the estimated values of susceptibles remaining in each country in mid July 2020.

At the end of June 2020, while the U.S. and South Korea did not seem to have an effective reproduction number under 1, Canada and Italy did have their effective reproduction number estimated to be Reff = 0.83, as seen from Fig. 1, Fig. 2. In their cases, we can redo our estimates for the 2 countries and compute the isolation rates due to testing and tracing so that they would have maintained their current value of Reff = 0.83 (see Table 3):

Table 3.

Model results for Italy and Canada for Reff = 0.83.

β s Reff κ = κ1 (1κ, 1κ1)
Italy 0.841 0.937 0.83 0.216 (4.62,4.62) days
Can 0.841 0.982 0.83 0.23 (4.33,4.33) days

In all cases, we chose γ=σ=12.5 for a Tser = 5 days and where s are the estimated values of susceptibles remaining in each country in mid July 2020.

3.2. Numerical estimates after the first pandemic wave

We present next pandemic mitigation scenarios under different testing and contact tracing rates, in the four countries under consideration in 2 cases: applied past the first wave (from July 2020 onward) and applied during the second wave (from November 2020 onward). We show how the theoretical estimates above arise in the context of the simulated pandemic evolution in each of the 4 countries up to July 1st, 2020, as a glimpse of what these policies could have accomplished. In subsection 3.3 below, we update our models and present the current situations, together with estimates on frequent testing and tracing that could have helped mitigate, at least in part, the second pandemic wave.

We depict first Canada and Italy (in Fig. 6 respectively), as they have similar estimates, in several respective testing and contact tracing scenarios. We clearly see that for values of κ1=κ11 shorter than the thresholds given in Table 2, a second pandemic wave is averted in each respective country. This threshold is the least stringent in Italy, where about 6% of the population (accounting for asymptomatic and/or unreported cases) is inferred to have been infected in the first wave, as opposed to Canada.

Fig. 6.

Fig. 6

Predicted daily cases in Italy (left) and Canada (right) under different rates of isolation due to testing, or testing plus contact-tracing, accompanied by a cessation of distancing measures.

The simulations for South Korea and the United States are presented in Fig. 7. We see that the isolation rates are the most stringent (lowest values in days) for the U.S., where the value of R0 inferred from the initial exponential rise of cases was higher at the end of June 2020 than those of the other three countries (≈1.2). In the case of the United States, a large-scale testing and tracing operation alone would not have been able to curtail their summer epidemic curve, thus social-distancing measures would still have been needed.

Fig. 7.

Fig. 7

Predicted daily cases in South Korea (left) and the US (right) under different rates of isolation due to testing, or testing plus contact-tracing, accompanied by a cessation of distancing measures.

3.3. Second waves and use of large-scale testing and tracing for control

Given the much higher infectious numbers in November 2020 vs. July 2020 as in Section 2.3, we see that testing and tracing at scale could have helped in the control of the pandemic (see Fig. 8), however they may have taken a while to curb down the incidence curve. In Italy's case, a testing and tracing strategy of 4 days would result in a sharp curbing down of the infected curve in approximately 2–3 weeks.

Fig. 8.

Fig. 8

The effects of testing and tracing on the current transmission levels in Italy during the second wave.

In Canada (see Fig. 9), if testing and tracing every 4 days were implemented at the end of November 2020, then the growth in infected cases could have been curbed down sharply in 2–3 weeks. In fact, all testing-only strategies, as well as testing & tracing, would have resulted in a much lower peak and a dramatic arrest of the infected curve.

Fig. 9.

Fig. 9

The effects of testing and tracing on the current transmission levels in Canada during the second wave.

In South Korea, which also experienced a resurgence (but with an effective reproduction number lower than in the first wave), a testing and tracing frequency of 4 days replacedwould have hadhas a similar effect as in Canada (see Fig. 10 - upper panel).

Fig. 10.

Fig. 10

The effects of testing and tracing on the current transmission levels in South Korea during the second wave.

In the case of US, a frequency of isolation due to testing and tracing every 3 days would have yielded the fastest results, with the most dramatic arrest of the infected curve (See Fig. 11). Even a frequency of 4 days would have curbed down the infections in approximately 6–8 weeks from November 2020 onward.

Fig. 11.

Fig. 11

The effects of testing and tracing on the current transmission levels in the United States during the second wave.

4. Vaccination and large-scale asymptomatic testing and tracing - Canada in January–April 2021

To illustrate the potential power and use of our policy (in line with current expert opinions (SchwartzAllison and Isaac, 2021)), we quantify its use in the context of Canada in the first four months of 2021, specifically December 21, 2020 to April 30, 2021, with two underlying elements that are different (and new) to 2021: the increasing vaccination coverage in the country, and the presence of variants of concern (VOCs) (University of Manitoba, 2021). The vaccination campaign has started quite slow in Canada throughout January and February, but accelerated in March and April. By the end of April 2021, Canada had approximately 12 million vaccinated individuals with the 1st dose, among which approximately 1 million fully vaccinated (with both doses) (Public Health Agency of C, 2021).

We are thus presenting a simulated scenario in which the vaccination campaign is implemented at a rate meant to reach the target of 12 million people in 130 days (December 21, 2020–April 30, 2021), with an efficacy of approximately 70% (Polack et al., 2020) by modifying the SEIRL model of Section 2 to feature a vaccinated compartment as follows:

dsdt=β(t)sieffρ(t)s,dedt=β(t)siσeκ1e,didt=σe(γ+κ)i,drdt=γi,dldt=κi+κ1e,dvdt=δ(t)effs,

where δ(t) is a time-dependant vaccination rate (implemented as a piecewise continuous function), while eff denotes the efficacy of the vaccine, which is averaged to be eff = 70%.

Furthermore, we note the presence of the time dependant β(t) which is meant to represent the evolution in Canada of VOCs among the 2020 baseline corona virus effective contact rate (Li, et al., 2020). In fact, we implement the presence of the variant as a weighted average of the base (2020) effective contact rate and the VOCs, where the VOCs are generally thought of being 50% more infectious:

β(t)w1(t)β+w2(t)βVOC=βt{Dec.25,20Jan.15,21}0.9β+0.1βVOCt{Jan.15,21Feb.10,21}0.7β+0.3βVOCt{Feb.10,21Mar.25,21}0.6β+0.4βVOCt{Mar.25,21Apr.30,21}0.5β+0.5βVOCt{Apr.15,21Apr.30,21},

where, according to (University of Manitoba, 2021) the VOCs account for 50% of all new cases in Canada by April 2021. We further recognize that Canada has been, on average, under some level of social-distancing measures throughout the Fall and into December 2020, thus the value of β ≈ γReff for an estimated value of Reff = 1.2, representing the reduction in the effective reproduction number at the beginning of January 2021, via collective NPI measures. Finally, we assume βVOC = 1.5β. In a similar piecewise fashion, we assume values of vaccination rate:

ρ(t)0.0005t{Dec.25,20Jan.15,21}0.0009t{Jan.15,21Feb.10,21}0.0022t{Feb.10,21Mar.25,21}0.0077t{Mar.25,21Apr.15,21}0.0083t{Apr.15,21Apr.30,21}

in such a a way that the cummulative vaccination uptake over January to April of 2021 matches by and large the available data https://health-infobase.canada.ca/covid-19/vaccination-coverage/

We then simulated four scenarios assuming that instead of stringent lockdown measures in March/April, the policy would have been to rapid-test at scale the population, on a regular basis. Specifically, we simulated a frequency of testing and tracing of every individual every 30 days, then every 20 days, every 14 days and every 7 days. We show our results in Fig. 13 below:It is clear that all levels of asymptomatic testing/tracing implemented would have helped keeping new cases under current level, while the vaccination campaign accelerated. To quantify directly our policy, we have computed the ration between the total number of new cases in each of the testing/tracing scenarios and the current total number of cases. We report our findings in Table 4 below:Evidently, a frequent testing and tracing policy could help in controlling new infections, and in keeping the number of new cases within safe healthcare capacity. As the vaccinating campaign in Canada is likely to last through July or end of August, depending on vaccine supply, the current policy can still be implemented while the campaign is in progress, in lieu of hard lockdown measures. Specifically, a frequency of an average of 20 days (red curve in Fig. 13) would have avoided the 3rd wave in Canada.

Fig. 13.

Fig. 13

The evolution of the epidemic in Canada, under various frequencies of testing and tracing over January 2021–May 2021. The curve of highest peak represents a non-NPI-mitigated curve, but in the presence of vaccines.

Table 4.

Various frequencies of testing and tracing coupled with vaccine uptake in Canada, January–April 2021.

(1κ,1κ1) Total simulated cases Total current cases Reduction percentage
(30d, 30d) 612188.9 721553 15.1567%
(20d, 20d) 402742.5 721553 44.1839%
(14d, 14d) 264235.8 721553 63.3795%
(10d, 10d) 173734.1 721553 75.922%

5. Discussion

In keeping with other published findings for these and other countries, our results suggest that the COVID-19 countermeasures taken in South Korea, Italy, Canada and the United States have had a substantial impact on the course of the disease during their pandemic waves. As illustrated in Fig. 8, Fig. 9, Fig. 10, Fig. 11, if a change in control strategy causes Reff to exceed 1, how quickly a second wave builds depends on the number of cases at the time the change has occurred.

In this work, we quantified the average level of repeated testing and tracing needed to allow a country to keep a near-normal functioning of society. Among the countries considered here, we estimate that a frequency of isolating individuals based on testing combined with contact-tracing raging from once every 6.2 days (Italy) to once every 3.5 days (U.S.) could have worked to keep the pandemic under a “slow-burn” control, if implemented in Summer 2020 (specifically July onward). A higher frequency of 4.5 days would have helped the second pandemic waves in Canada, Italy and South Korea, while 3 days would help in the case of the US. Last but not least, a testing and tracing frequency of 20 days, on average, for Canada would have mitigated the 3rd wave, in the presence of vaccination.

Of the four countries, only South Korea has managed to not only ramp up and sustain large-scale testing, but also to convince its population to adopt tracing technology and adhere to strict isolation rules, certainly during the first wave. Testing capacity is up considerably in Italy, Canada and the US, however is only used as a reactive strategy for symptomatic individuals. A proactive testing and tracing strategy, such as voluntarily testing people in a repeated fashion in schools, manufacturing, airports, etc., (see for instance our work in (Cojocaru et al., 2021)) may have yielded better pandemic control.

Our policy scenarios here are subject to a number of limitations, of which we highlight two main ones. Our estimates assume testing with sensitivity at or near 100% and immediate isolation once a subject tests positive. Though reaching these targets would necessitate an undeniably large logistic effort, home-test kits availability3 combined with further advances in mobile device-based contact tracing can make these strategies possible. Canada started to test its electronic platform for voluntary participation in contact tracing in July 2020, with Ontario being the first province to test it on a larger scale (Covid-19 alert app starts, 2021). However, the adoption rate of the Covid-tracing app is approximately 10–15% for instance in Canada. Moreover, the lower than 100% accuracy of some of the rapid testing kits available, as well as their false positive or false negative rates may make the frequent implementation of large scale testing less attractive. Thus, one possible workaround is to employ pool testing (Žilinskas, Lančinskas, & Guarracino, 2021) or frequent random testing in smaller scale populations, such as schools (Cojocaru et al., 2021), manufacturing plants, etc., where pathogen transmission is known to be higher, and test less frequently parts of the population who are not as exposed.

The second limitation is that we are simulating large, heterogeneous, geographically widely-distributed populations with an unstratified disease transmission model. Although we have taken the proportion of asymptomatic COVID-19 cases to be 50%, informed by a recent CDC report, assuming asymptomatic infection confers immunity, this would mean a smaller remaining pool of susceptibles and thus a lower current effective reproduction number. Estimates of R0 from time series data of cases depend, as always, on the assumed latent and infectious periods. As we have demonstrated through (Fig. 5), if these periods are longer than the isolation time, then it is the latter which principally drives the disease dynamics. Thus, our findings about threshold isolation times are relatively robust against the possibility of a substantially longer COVID-19 serial interval.

Last but not least, testing and tracing policies are strongly dependent on public cooperation and compliance. As populations are becoming more anxious to resume normal work, school and social schedules, compliance with measures is harder to enforce. Populations must be relied on to comply with self-isolation if testing positive for the virus, as well as self-isolation upon being exposed to an infected person. Sustainable supply chains, accuracy and reliability of possible tests, as well as privacy issues around electronic contact tracing technology all present importantissues countries must analyze. Finally, even with availability of effective vaccines and treatments, testing and tracing policies together with NPI measures could be policies to strive for in the immediate short-term, to avoid strong lockdown and shelter-in-place measures.

Acknowledgements

M. G. Cojocaru acknowledges support from the National Science and Engineering Research Council of Canada, Discover Grant 400684 (PI: Cojocaru, support for: Fields, Humphrey, Nahirniak), from National Science and Engineering Research Council of Canada, Discovery Accelerator 401285 (PI: Cojocaru, support for: Migot) and from National Science and Engineering Research Council of Canada, Collaborative Research ∖& Development grant 401569 (PI: Cojocaru, support for: Fields, Humphrey).

Handling editor: Dr HE DAIHAI HE

Footnotes

Peer review under responsibility of KeAi Communications Co., Ltd.

1
In the limit as σ, the SEIR model reduces to the SIR model, and accordingly, as can readily be shown by L'Hospital's rule.
limσ=(ρSEIR+σ)(ρSEIR+γ)σγ=ρSIR+γγ. (8)
3

A recent discussion on home-test kits this can be found in “COVID-19: A cheap, simple way to control the coronavirus” analysis https://www.nytimes.com/2020/07/03/opinion/coronavirus-tests.html.

Appendix.

Local exponential growth around a disease free equilibrium with s(0) ≤ 1 in an SEIRL model

We want to find a relation between the exponential growth of the infected compartment in an SEIRL model (13) and the reproductive number R0 around a disease-free equilibrium of the type (s(0)=s~1,0,0,0) which arises as a possibility in a first wave (s~=1) or a second wave of a pandemic such as COVID-19 (s~<1).

In this case, we conduct a similar computation as in (Ma, 2020), but considering the 4 dimensional system of equations for s, e, i, l leads us to the Jacobian of the SEIRL:

J=βi0βs0βi(σ+κ1)βs00σ(γ+κ)000κ0.

If computed at the disease free equilibrium (s~,0,0,0) we further obtain:

J=00βs~00(σ+k1)βs~00σ(γ+κ)000κ+κ10.

Again we note that the linearized equations for s and l are decoupled from the equations of e and i, thus, to get information on the growth rate of the infected compartment, let us try to solve the linearized reduced system in (e, i) based on the reduced Jacobian:

Jreduced=(σ+κ1)βs~σ(γ+k)Solve:det(ρI2Jreduced)=0

Its characteristic equation is:

ρ2ρ((σ+κ1)+(γ+κ))+(σ+κ1)(γ+κ)σβs~=0

The eigenvalues of this matrix can be computed to be

ρ1,2=(σ+κ1+γ+κ)2±
(σ+κ1+γ+κ)24((σ+κ1)(γ+κ)σβs~)2
ρ1,2=(σ+κ1+γ+κ)±((σ+κ1)(γ+κ))2+4σβs~2 (13)

We first note that ((σ+κ1)(γ+κ))2+4σβs~>0, given all parameters are positive. This implies that ρ1ρ2R and clearly ρ2 < 0. We check whether ρ1 > 0 by looking at

((σ+κ1)(γ+κ))2+4λβs~>σ+κ1+γ+κ
(σ+κ1)(γ+κ)2+4λβs~>((σ+κ1)+(γ+κ))2
2(σ+κ1)(γ+κ)+4σβs~>2(σ+κ1)(γ+κ)
σβs~>(σ+κ1)(γ+κ)βs~>(σ+κ1)(γ+κ)σβ

Therefore, as before, we have that

ρ1>0 as long as s~>(σ+κ1)(γ+κ)σβ (14)

Inequality (14) simply shows that in order to not have an exponential growth from our disease free equilibrium (in other words the infection dies out), we need to allow that the initial fraction of susceptibles is lower than

s~(σ+κ1)(γ+κ)σβ

We note that β and γ are disease-dependent values on which we cannot exert control. However, κ and κ1 are parameters on which we can exert an exogenous control (specifically to increase them, thus raising the upper bound on fractions s~ with no exponential growth in infected) which will be outlined in detail in the next section.

Continuing as in (Ma, 2020), we express β as a function of s~,σ,γ,κ,κ1 from (13) and we get:

2ρ1+(σ+κ1)+(γ+κ)=((σ+κ1)(γ+κ))2+4σβs~
4ρ12+(σ+κ1)2+2(σ+κ1)(γ+κ)+(γ+κ)2+4ρ1(σ+κ1)+4ρ1(γ+κ)=
(σ+κ1)22(σ+κ1)(γ+κ)+(γ+κ)2+4σβs~
4ρ12+4(σ+κ1)(γ+κ)+4ρ1(σ+κ1)+4ρ1(γ+κ)=4σβs~
ρ12+(σ+κ1)(γ+κ)+ρ1(σ+κ1)+ρ1(γ+κ)σs~=β
(σ+κ1+ρ1)(γ+κ+ρ1)σs~=β

Following (van den Driessche, 2017), we can use the next generation matrix to deduce R0 as the dominant eigenvalue of the next generation matrix:

FV1=βσs~(σ+κ1)(γ+κ)βs~γ+κ00R0=βσs~(σ+κ1)(γ+κ)

Now using the expression of β in that of R0 we are able to express the effective reproductive number as a function of the exponential growth and of γ, σ, κ, κ1:

R0=σs~(σ+κ1)(γ+κ)(σ+κ1+ρ1)(γ+κ+ρ1)σs~
R0=(σ+κ1+ρ1)(γ+κ+ρ1)(σ+κ1)(γ+κ) and Reff=s(t)R0,t>0

Similar to (5) we denote by R0S(Q)EIRL:

R0SEIRL=(σ+κ1+ρ1)(γ+κ+ρ1)(γ+κ)σ

Clearly, if κ = κ1 = 0 then R0SEIRL reduces to R0SEIR in (5) of Section 2.

Let us now note that we have shown that the exponential growth factor (13), as well as the R0SEIRL, are dependent on the rates κ and κ1, that is to say, we denote by

ρ(κ,κ1)=(σ+κ1+γ+κ)+((σ+κ1)(γ+κ))2+4σβs~2,
 and by R0(κ,κ1)=(σ+κ1+ρ1)(γ+κ+ρ1)(γ+κ)σ

The reproductive number as a function of Tlat

Let us express the reproductive number, in general, as a function of Tlat=1σ and Tser=Tinf+Tlat=1γ=TserTlatγ=1TserTlat.

From 5 we have that

R0=(ρ+γ)(ρ+σ)γσ=ρ+1Tlatρ+1TserTlat1Tlat(TserTlat)
=(ρTlat+1)(ρ(TserTlat)+1).

Then

R0=(TlatρTserρ1)(Tlatρ+1)
dRdTlat=ρ(Tlatρ+1)(TlatρTserρ1)ρ

where we can solve for a Tlat value which maximizes R0, namely

dRdTlat=02Tlatρ+TserρTlat=Tser2.

Italy, South Korea and US fits, spring to fall

Fig. 14.

Fig. 14

Italy - daily incidence and log-daily incidence fits to November 2020. (A) Upper panels: Linear and semi-log plots of daily incidence data of confirmed cases in Italy, together with maximum-likelihood model fit (“with measures, confirmed”) Also shown is the inferred true number of infected, taking into account under-reporting and asymptomatic cases (“with measures, all”). Shown for comparison are the number of confirmed cases (“no measures, confirmed”) and all cases (“no measures, all”) expected to have occurred in the absence of countermeasures. (B) Lower panels: Cumulative incidence (top) and inferred reduction of effective contacts (β), together with the corresponding effective reproduction numbers (vertical numbers) (bottom).

Fig. 15.

Fig. 15

South Korea - daily incidence and log-daily incidence fits to November 2020. (A) Upper panels: Linear and semi-log plots of daily incidence data of confirmed cases in Italy, together with maximum-likelihood model fit (“with measures, confirmed”) Also shown is the inferred true number of infected, taking into account under-reporting and asymptomatic cases (“with measures, all”). Shown for comparison are the number of confirmed cases (“no measures, confirmed”) and all cases (“no measures, all”) expected to have occurred in the absence of countermeasures. (B) Lower panels: Cumulative incidence (top) and inferred reduction of effective contacts (β), together with the corresponding effective reproduction numbers (vertical numbers) (bottom).

Last but not least, the US has never staved off their first pandemic wave, moving into a second wave in Summer 2020 and then a dramatic 3rd wave (Fig. 16). In all four countries, interventions arrested the initial exponential rise in cases and brought the effective reproduction number below 1. In Italy, South Korea and Canada, daily case numbers have since been brought far below their peak values through the summer of 2020, but entered a second wave in the fall. The US has never staved off their first pandemic wave, moving into a second wave in Summer 2020 and then a 3rd wave (Fig. 16).

If we quantify the average β in the four countries we see that, for instance, Canada, Italy and US have managed to maintain an average of 40%–50% reduction factors through social distancing measures, however the US has implemented the measures with a larger initial delay (so at much higher initial daily incidence) and larger heterogeneity than Canada, thus their pandemic curves have evolved differently. In South Korea, the average β reduction is higher, at around 70%.

South Korea (see Fig. 15) experienced a very similar early exponential growth in cases, and hence has a similar inferred R0, as the other three countries. However, its mitigation and control measures stood out from the beginning in the fact that the country employed a rapid scale-up of testing, concurrent with contact tracing and isolating of infected individuals. In fact its higher reduction in β is clearly seen. There were also social distancing measures imposed, but notably no shelter-in-place (McNeil, 2020). Last but not least, mask wearing is a regular policy that the population adopts widely (not only for this pandemic, but also for flu).

Fig. 16.

Fig. 16

United States - daily incidence and log-daily incidence fits to November 2020. (A) Upper panels: Linear and semi-log plots of daily incidence data of confirmed cases in Italy, together with maximum-likelihood model fit (“with measures, confirmed”) Also shown is the inferred true number of infected, taking into account under-reporting and asymptomatic cases (“with measures, all”). Shown for comparison are the number of confirmed cases (“no measures, confirmed”) and all cases (“no measures, all”) expected to have occurred in the absence of countermeasures. (B) Lower panels: Cumulative incidence (top) and inferred reduction of effective contacts (β), together with the corresponding effective reproduction numbers (vertical numbers) (bottom).

References

  1. Alvarez P. CNN; 2020. Here's what trump's coronavirus emergency declaration does. [Google Scholar]
  2. Anastassopoulou C., Russo L., Tsakris A., Siettos C. Data-based analysis, modelling and forecasting of the covid-19 outbreak. PloS One. 2020;15(3) doi: 10.1371/journal.pone.0230405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashleigh R.T., Bogoch I., Ryan S., Watts A., Fisman D.N., Khan K. medRxiv; 2020. Estimation of covid-2019 burden and potential for international dissemination of infection from Iran. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashleigh R.T., Ng V., Rees E., Fisman D. Estimation of covid-19 outbreak size in Italy. The Lancet. Infectious Diseases. 2020;20(5):537. doi: 10.1016/S1473-3099(20)30227-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bi Q., Wu Y., Mei S., Ye C., Zou X., Zhang Z. The Lancet Infectious Diseases; 2020. Epidemiology and transmission of covid-19 in 391 cases and 1286 of their close contacts in shenzhen, China: A retrospective cohort study. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CBC News . CBC News; 2020. Coronavirus: Here's what's happening on march 22. [Google Scholar]
  7. Centor R.M., Fisman D.N. Annals of internal medicine. OC1–OC1; 2020. Annals on call-understanding the spread of covid-19. [DOI] [PubMed] [Google Scholar]
  8. Cereda D., Tirani M., Rovida F., Demicheli V., Ajelli M., Poletti P. Italy.. arXiv; 2003. The early phase of the covid-19 outbreak in lombardy. [Google Scholar]
  9. Cojocaru M. G. Najafabadi M. N. Wu J. Asgary, A. Simulating preventative testing of sars-cov-2 in schools: Policy implications. BMC Public Health 21, Article 125, 2021. [DOI] [PMC free article] [PubMed]
  10. Covid-19 alert app starts beta testing after three-week delay. 2021. https://www.cp24.com/news/covid-19-alert-app-starts-beta-testing-after-three-week-delay-1.5036434 Accessed: 2021-01-21.
  11. Cowan G. Oxford university press; 1998. Statistical data analysis. [Google Scholar]
  12. D'Emilio F. The Associated Press; 2020. Europe hopeful as Italy's daily coronavirus death toll falls to lowest in weeks. [Google Scholar]
  13. Dong E., Du H., Gardner L. The Lancet Infectious Diseases; 2020. An interactive web-based dashboard to track covid-19 in real time. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. van den Driessche P. Reproduction numbers of infectious disease models. Infectious Disease Modelling. 2017;2(3):288–303. doi: 10.1016/j.idm.2017.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ferguson N., Laydon D., Gilani G.N., Imai N., Ainslie K., Baguelin M. 2020. Report 9: Impact of non-pharmaceutical interventions (npis) to reduce covid19 mortality and healthcare demand. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ganyani T., Kremer C., Chen D., Torneri A., Faes C., Wallinga J. Estimating the generation interval for coronavirus disease (covid-19) based on symptom onset data, march 2020. Euro Surveillance. 2020;25(17):2000257. doi: 10.2807/1560-7917.ES.2020.25.17.2000257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guan W.-jie, Ni Z.-yi, Hu Y., Liang W.-hua, Ou C.-quan, He J.-xing. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. 2021. John's Hopkins COVID-19 data.https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data Accessed: 2021-01-21. [Google Scholar]
  19. Kissler S.M., Tedijanto C., Goldstein E., Grad Y.H., Lipsitch M. Projecting the transmission dynamics of sars-cov-2 through the postpandemic period. Science. 2020 doi: 10.1126/science.abb5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R. The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine. 2020;172(9):577–582. doi: 10.7326/M20-0504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Laydon D., Nedjati-Gilani G., Ferguson N.M. 2020. Impact of non-pharmaceutical interventions (npis) to reduce covid-19 mortality and healthcare demand. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Li Q., Tang S., Xiao Y., Wu J., Tang B., Bragazzi N.L. An updated estimation of the risk of transmission of the novel coronavirus (2019-ncov) Infectious Disease Modelling. 2020;5:248–255. doi: 10.1016/j.idm.2020.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liu M., Arora R.K., Krajden M. Rapid antigen tests for sars-cov-2. Canadian Medical Association Journal. 2021;193(13) doi: 10.1503/cmaj.202827. E447–E447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ma J. Estimating epidemic exponential growth rate and basic reproduction number. Infectious Disease Modelling. 2020 doi: 10.1016/j.idm.2019.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McNeil D.G., Jr. The virus can be stopped, but only with harsh measures, experts say. The New York Times. 2020 [Google Scholar]
  26. R.A Neher, R. Dyrdak, V. Druelle, Emma B H., and J. Albert. Potential impact of seasonal forcing on a sars-cov-2 pandemic. Swiss Medical Weekly, 150(1112), 2020. [DOI] [PubMed]
  27. Ogilvy Kermack W., McKendrick A.G. A contribution to the mathematical theory of epidemics. Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character. 1927;115(772):700–721. [Google Scholar]
  28. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S. Safety and efficacy of the bnt162b2 mrna covid-19 vaccine. New England Journal of Medicine. 2020;383(27):2603–2615. doi: 10.1056/NEJMoa2034577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Public Health Agency of Canada . 2021. Covid-19 vaccination information on vaccine doses administered and vaccination coverage. [Google Scholar]
  30. Russell T.W. Using a delay-adjusted case fatality ratio to estimate under-reporting. https://cmmid.github.io/topics/covid19/global_cfr_estimates.html retrieved 2020-11-20, 2020. Accessed: 2020-11-20.
  31. Russell T.W., Hellewell J., Abbott S., Golding N., Gibbs H., Jarvis C.I. Centre for Mathematical Modeling of Infectious Diseases Repository; 2020. Using a delay-adjusted case fatality ratio to estimate under-reporting; pp. 1–6. [Google Scholar]
  32. Schwartz K.L., Allison J.M.G., Isaac I.B. Rapid antigen screening of asymptomatic people as a public health tool to combat covid-19. Canadian Medical Association Journal. 2021;193(13):E449–E452. doi: 10.1503/cmaj.210100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tang S., Bragazzi N.L., Li Q., Sun X., Liang J., Xiao Y. The evolution of quarantined and suspected cases determines the final trend of the 2019-ncov epidemics based on multi-source data analyses. International Journal of Infectious Diseases. 2020 Accepted. [Google Scholar]
  34. Tindale L., Coombe M., Stockdale J.E., Garlock E., Lau W.Y.V., Saraswat M. 2020. Transmission interval estimates suggest pre-symptomatic spread of covid-19. medrxiv. Preprint] doi, 10(2020.03):03–20029983. [Google Scholar]
  35. University of Manitoba . 2021. National collaborating centre for infectious diseases. [Google Scholar]
  36. Žilinskas J., Lančinskas A., Guarracino M.R. Pooled testing with replication as a mass testing strategy for the covid-19 pandemics. Scientific Reports. 2021;11(1):1–7. doi: 10.1038/s41598-021-83104-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Disease Modelling are provided here courtesy of KeAi Publishing

RESOURCES